Clinical Trial Update: Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease [NA]

View source ↗

Summary

The clinical trial evaluating SCALE PET software for quantitative brain PET analysis in Alzheimer's disease and mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: NEUROPHET | Conditions: Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) | NA | Status: COMPLETED